The Effect of Web-Based Education in Patients With Type 2 Diabetes

Sponsor
Mehmet Akif Ersoy University (Other)
Overall Status
Completed
CT.gov ID
NCT04626531
Collaborator
Akdeniz University (Other)
89
2
27.1

Study Details

Study Description

Brief Summary

This research was designed as a randomized controlled study to develop a web-based training program and evaluate the program's impact on diabetes management. This research was carried out on 89 patients diagnosed with type 2 diabetes in the Department of Endocrinology and Metabolic Diseases of Akdeniz University. The preparation of the web page and its content has benefited from the latest literature, national and international websites, and expert opinions. Individuals in the survey scope have been stratified random method with as intervention group (n=44) and control group (n=45). Individuals who were taken in the initiative group were informed by web page, SMS, e-mail prepared for a period of three months. Personal information forms Metabolic Control Variable Form, Diabetes Self-Care Activities Questionnaire, Self-Efficacy Scale for Type 2 Diabetic Individuals, Diabetes-Specific Quality of Life Scale and Web Site Analysis and Measurement Inventory were used as the data tools. The informed consent was obtained from the patients and all data were collected by author during face-to-face interviews.

Condition or Disease Intervention/Treatment Phase
  • Other: Web-Based Education
  • Other: Control Group
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
89 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Masking Description:
They did not know if they were in the control and intervention group at the time of randomization.
Primary Purpose:
Supportive Care
Official Title:
The Effect of Web-Based Education Program on Metabolic Control, Self-Care Activities, Self-Efficacy and Quality of Life in Patients With Type 2 Diabetes: A Randomized Controlled Trial
Actual Study Start Date :
Jan 10, 2016
Actual Primary Completion Date :
Feb 15, 2017
Actual Study Completion Date :
Apr 15, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention Group

After the pre-tests (Self-Care Activities, Self-Efficacy, Quality of Life) , the patients were given web based education and containing information and recommendations on self-management strategies for three months.

Other: Web-Based Education
Participants in the intervention group had unlimited access to the Web site, free of charge. The Web site was designed to run on personal computers and smartphones.

Experimental: Control Group

The control group didn't apply any interference during the study. Participants in the control group continued their routine follow-up.

Other: Control Group
The control group didn't apply any interference during the study. Participants in the control group continued their routine follow-up.

Outcome Measures

Primary Outcome Measures

  1. Metabolic Control Variable Form [5 minute]

    It is a 9-item information form that questions the participants' clinical measurements including height, weight, body mass index, blood pressure, and laboratory results including blood glucose, HbA1c, cholesterol, triglyceride, and microalbuminuria level.

  2. The Diabetes Self-Care Activities Questionnaire [5 minute]

    The Diabetes Self-Care Activities Questionnaire was developed by Toobert and Glasgow to determine the self-care activities of individuals with diabetes. The Turkish validity and reliability of the questionnaire were conducted by Kav et al. (2010) and the total Cronbach alpha value was found 0.72. The tool contains 11 items, which measure the frequency of performing dia- betes self-care activities over the last seven days including diet, exercise, blood glucose testing, foot care and tobacco use. The scale total score ranges between 0-7. Higher scores indicate more self-care activities.

  3. The Self-Efficacy Scale for Patients with Type 2 Diabetes Mellitus [5 minute]

    The Self-Efficacy Scale for Patients with Type 2 Diabetes Mellitus was developed in 1999 by Van der Bijl et al. The Turkish validity and reliability of the scale were performed by Kara et al. (2006). The total Cronbach alpha value was found to be 0.88. The scale consists of 20 items in 5-point Likert type. Responses to the scale; "Yes, I'm sure" 5 points "No, I'm not sure" are evaluated as 1 point. The scale total score ranges between 20-100. High scores according to scale total scores indicate good self-efficacy.

  4. The Diabetes Quality of Life Scale [5 minute]

    The Diabetes Quality of Life Scale was developed by Jacobson et al to evaluate the quality of life of individuals with diabetes (Jacobson, Groot, & Samson, 1994). The Turkish validity and reliability study of the scale was conducted by Yıldırım et al (2007). The total Cronbach alpha value of the scale was found to be 0.89. The scale total score ranges between 46-230. High scores according to scale total scores indicate good quality of life.

Secondary Outcome Measures

  1. Website Analysis and Measurement Inventory [5 minute]

    The Website Analysis and Measurement Inventory is a scale based on software evaluation for usability and international software standards. WAMMI is used for the evaluation of websites in many areas. The inventory includes the sub-dimensions of attractiveness, controllability, efficiency, helpfulness, learnability, global usability. The scale total score ranges between 0-100. The scores on the WAMMI are given as percentages, higher percentages indicate higher usability.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Between the ages of 18-65

  • Diagnosed with type 2 diabetes at least six months ago

  • Not have communication disabilities

  • Used insulin

  • Phone and internet connection

Exclusion Criteria:
  • Have a physical, cognitive or mental disability to answer questions

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Mehmet Akif Ersoy University
  • Akdeniz University

Investigators

  • Study Chair: Mustafa Kemal Balci, Proof, Akdeniz University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Nurten Terkes, Principal Investigator, Mehmet Akif Ersoy University
ClinicalTrials.gov Identifier:
NCT04626531
Other Study ID Numbers:
  • MAKU
First Posted:
Nov 12, 2020
Last Update Posted:
Nov 13, 2020
Last Verified:
Nov 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Nurten Terkes, Principal Investigator, Mehmet Akif Ersoy University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 13, 2020